![](/img/cover-not-exists.png)
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
Infante, Jeffrey R., Somer, Bradley G., Park, Joon Oh, Li, Chung-Pin, Scheulen, Max E., Kasubhai, Saifuddin M., Oh, Do-Youn, Liu, Yuan, Redhu, Suman, Steplewski, Klaudia, Le, NgocdiepVolume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2014.04.024
Date:
August, 2014
File:
PDF, 979 KB
english, 2014